| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/27/2007 | US20070224123 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 09/27/2007 | US20070224122 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 09/27/2007 | US20070224121 Connective Tissue Growth Factor-4 |
| 09/27/2007 | US20070224118 Methods for soluble zalpha11 cytokine receptors |
| 09/27/2007 | CA2647769A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 09/27/2007 | CA2647096A1 Complexes of nadp with the protein maba of mycobacterium tuberculosis or with mutants thereof, and their uses for designing and screening antibiotics |
| 09/27/2007 | CA2647027A1 Neuromedin u receptor agonists and uses thereof |
| 09/27/2007 | CA2646643A1 Methods for preventing and treating amyloidogenic diseases |
| 09/27/2007 | CA2646476A1 Stress resistant plants |
| 09/27/2007 | CA2646471A1 Novel genes encoding insecticidal proteins |
| 09/27/2007 | CA2646004A1 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis |
| 09/27/2007 | CA2645983A1 Identification of crmp4 as a convergent regulator of axon outgrowth inhibition |
| 09/27/2007 | CA2645930A1 Methods of binding of cross-beta structures by chaperones |
| 09/27/2007 | CA2645844A1 Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation |
| 09/27/2007 | CA2641064A1 Antimicrobial protein |
| 09/27/2007 | CA2638977A1 D-amino acid selection for soybean |
| 09/27/2007 | CA2638772A1 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
| 09/27/2007 | CA2638755A1 Methods and compositions for antagonism of rage |
| 09/27/2007 | CA2637785A1 Glycosylated g-csf |
| 09/27/2007 | CA2637137A1 A novel method of protecting islet cells from apoptosis during the donor harvesting process |
| 09/26/2007 | EP1837399A1 Anticancer agent |
| 09/26/2007 | EP1837346A2 Method for purifying granulocyte-colony stimulating factor |
| 09/26/2007 | EP1837345A1 Pharmaceutical compositions comprising cholesteryl-alpha-glucosyltransferase for the treatment of Helicobacteri pylori infections |
| 09/26/2007 | EP1837344A1 Tumor necrosis factor receptor-derived peptide analogues |
| 09/26/2007 | EP1837342A2 Sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 09/26/2007 | EP1837031A1 Compositions and methods for treating diabetes |
| 09/26/2007 | EP1836319A2 Polypeptides having nucleic acid binding activity and compositions and methods for nucleic acid amplification |
| 09/26/2007 | EP1836316A2 Methods for expression and purification of recombinant human growth hormone |
| 09/26/2007 | EP1836315A2 Zebrafish heterotrimer g-protein gamma 2 subunit (gng2) |
| 09/26/2007 | EP1836314A2 Modified human growth hormone |
| 09/26/2007 | EP1836309A2 Reconstituted human breast tumor model in mouse |
| 09/26/2007 | EP1836305A1 Expression vectors for treating bacterial infections |
| 09/26/2007 | EP1836304A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and uses thereof |
| 09/26/2007 | EP1836224A1 Bcma polypeptides and uses thereof |
| 09/26/2007 | EP1836223A2 Hemopexin-like structure as polypeptide-scaffold |
| 09/26/2007 | EP1836222A1 Biopolymer including prolamin and methods of making it |
| 09/26/2007 | EP1836221A2 Gram positive bacterial cells comprising a disrupted flagellin gene, flagellin-based fusion proteins and use in removal of metal ions from a liquid |
| 09/26/2007 | EP1836220A1 Modified flagellins and flagellar filaments useful as receptors and methods for the preparation thereof |
| 09/26/2007 | EP1836219A2 Actinomadura chromoprotein, apoprotein, and gene cluster |
| 09/26/2007 | EP1836218A2 Methods and compositions for induction or promotion of immune tolerance |
| 09/26/2007 | EP1835929A2 Anti-kir combination treatments and methods |
| 09/26/2007 | EP1835927A1 Modified beta thymosin peptides |
| 09/26/2007 | EP1756148A4 Insecticidal toxin complex fusion proteins |
| 09/26/2007 | EP1725661A4 Polynucleotides for the detection of escherichia coli o157 |
| 09/26/2007 | EP1706485B1 EMPTY CAPSIDS (VLPs(-VP4)) OF THE INFECTIOUS BURSAL DISEASE VIRUS (IBDV), OBTAINMENT PROCESS AND APPLICATIONS |
| 09/26/2007 | EP1699926A4 Stress tolerant plants and methods thereof |
| 09/26/2007 | EP1653808A4 Neurogenin3 and production of pancreatic islet cells |
| 09/26/2007 | EP1620539A4 Transgenic plants with increased glycine-betaine |
| 09/26/2007 | EP1610802A4 Parkin interacting polypeptides and methods of use |
| 09/26/2007 | EP1578909A4 Excitatory glycine receptors and methods |
| 09/26/2007 | EP1495142B1 "doping" in walk-through mutagenesis |
| 09/26/2007 | EP1409740B1 Asthma-associated gene |
| 09/26/2007 | EP1363949B1 Functional fragment of the leptine receptor |
| 09/26/2007 | EP1276860B1 Databases of regulatory sequences; methods of making and using same |
| 09/26/2007 | EP1272510B1 Pharmacologically active antiviral peptides and methods of their use |
| 09/26/2007 | EP1237571B1 Toscana virus nucleoprotein |
| 09/26/2007 | EP1222255B1 Polypeptide fragments comprising c-terminal portion of helicobacter catalase |
| 09/26/2007 | EP1198250B1 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 09/26/2007 | EP1194447B1 Novel potassium channels and genes encoding these potassium channels |
| 09/26/2007 | EP1141005B1 Method for identifying hif-1alpha modulators |
| 09/26/2007 | EP1086132B1 Gene encoding organic anion transporter |
| 09/26/2007 | EP1035865B1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/26/2007 | EP0991663B1 Mycobacterium strain with modified erp gene and vaccine composition containing same |
| 09/26/2007 | EP0975972B1 Methods for identifying cell cycle regulators |
| 09/26/2007 | EP0787191B1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 09/26/2007 | CN101044247A Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 09/26/2007 | CN101044242A Tumor specific antibody |
| 09/26/2007 | CN101044239A Mammalian cell culture processes for protein production |
| 09/26/2007 | CN101044236A Mycer immortalized hepatocyte |
| 09/26/2007 | CN101044162A Glp-1 analog fusion protein formulations |
| 09/26/2007 | CN101044161A A purified arabinogalactan-protein (agp) composition |
| 09/26/2007 | CN101044160A Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 09/26/2007 | CN101044159A Method for producing L-amino acids using bacteria of the enterobacteriaceae family |
| 09/26/2007 | CN101044158A Chemokine binding activity of viral TNF receptors and related proteins |
| 09/26/2007 | CN101044154A Chimeric molecules for cleavage in a treated host |
| 09/26/2007 | CN101041824A Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 09/26/2007 | CN101041823A Gene encoding protein having trehalose synthesis-promoting activity and use thereof |
| 09/26/2007 | CN101041822A Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 09/26/2007 | CN101041819A High level expression of human erythropoietin gene in stably transfected mammalian cells. |
| 09/26/2007 | CN101041818A Method for recombinant production of pancreatic glucagons sample peptide-2 |
| 09/26/2007 | CN101041694A Angiogenin-like protein V and preparation method thereof, its polyclonal antibody and uses thereof |
| 09/26/2007 | CN101041693A Novel blood sugar lowing polypeptide and uses thereof |
| 09/26/2007 | CN101041692A Scorpion analgesic antibacterial active peptide and preparation method thereof |
| 09/26/2007 | CN101041691A Chinese south China sea signal taro snail nerve toxin gene 1t5.4 and uses thereof |
| 09/26/2007 | CN101041690A Recombinant dog hookworm coagulate peptide resistant 5 mutant, its encoding gene, preparation and application thereof |
| 09/26/2007 | CN101041685A Refolding method of gene engineering recombinant cattle interleukins-2 |
| 09/26/2007 | CN100339482C Hybrid expression of neisserial proteins |
| 09/26/2007 | CN100339480C Halotolerant, drought resistance gene from Thellugiella halophila, coded protein and application |
| 09/26/2007 | CN100339479C Gene participating in the synthesis of brassinosteroid |
| 09/26/2007 | CN100339475C Colibacillns strain for recombination producing lectin of snowdrop and method thereof |
| 09/26/2007 | CN100339395C E type hepatitis virus monoclonal antibody or its conjugated active fragment and use thereof |
| 09/26/2007 | CN100339394C 组织特异性表达 Tissue-specific expression |
| 09/26/2007 | CN100339393C PEG-conjugates of HGF-NK4 |
| 09/26/2007 | CN100339392C Liver cancer apoptosis inducing factor and its encoding gene and use |
| 09/26/2007 | CN100339391C Coronavirus (SARS-CoV)B-cell antigen determinate cluster with extensive cross immune activity |
| 09/26/2007 | CN100339388C New assays for preimplantation factor and preimplantation factor peptides |
| 09/26/2007 | CN100339387C Method for preparing antler polypeptide and medicine with the antler polypeptide as main active component |
| 09/26/2007 | CN100339131C IHNV G protein for immune stimulation |
| 09/26/2007 | CN100339130C 疫苗 Vaccine |
| 09/25/2007 | US7273975 Inbred maize line PHB6V |